Chetan Pratap Pujara
Chief R&D Officer · SpyGlass Pharma, Inc.
Individual
- 2026
- Feb 9, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Chetan Pratap Pujara files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $59.04M in SGP purchases and sales in the last 12 months
- Anthony A. Florence Jr. - $15.00M in SGP purchases and sales in the last 12 months
- Edward T. Mathers - $15.00M in SGP purchases and sales in the last 12 months
- Paul Edward Walker - $15.00M in SGP purchases and sales in the last 12 months
- Forest Baskett - $15.00M in SGP purchases and sales in the last 12 months
- Scott D. Sandell - $15.00M in SGP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Chetan Pratap Pujara?
Chetan Pratap Pujara is a corporate insider, tracked as Chief R&D Officer of SpyGlass Pharma, Inc. (SGP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Chetan Pratap Pujara last file a Form 4?
The only primary Form 4 on record is dated 9 February 2026.